Preclinical studies have confirmed that IMD-0354 significantly suppresses the growth of melanoma and hepatocellular carcinoma (HCC) through competitive inhibition of SLC1A5 (152, 153). The gene discussed is SLC1A5; the disease is hepatocellular carcinoma.